Hyperthermic intraperitoneal chemotherapy and cytoreductive surgery for peritoneal carcinomatosis of colorectal origin: A novel treatment strategy with promising results in selected patients

Colorectal Disease

Volumn 8, Issue 7, 2006, Pages 544-550

  Moran, Brenda J ^a   Meade, B ^a   Murphy, E ^a  

^a NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

Author keywords

Colorectal carcinomatosis; Cytoreduction; Hyperthermic intraperitoneal chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; OXALIPLATIN;

ABDOMINAL SURGERY; APPENDIX CANCER; CANCER MORTALITY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; COLORECTAL CANCER; CYTOREDUCTIVE SURGERY; HEMATOLOGIC DISEASE; HUMAN; HYPERTHERMIC THERAPY; IMAGING SYSTEM; LAPAROSCOPIC SURGERY; LIVER METASTASIS; MEDICAL DECISION MAKING; MORBIDITY; NEUTROPENIA; PATIENT SELECTION; PERITONEUM METASTASIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SURGICAL TECHNIQUE; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR LOCALIZATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; COLORECTAL NEOPLASMS; HUMANS; HYPERTHERMIA, INDUCED; NEOPLASM, RESIDUAL; PERITONEAL NEOPLASMS;

EID: 33747056841     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2006.01050.x     Document Type: Review

References (35)

1. Sugarbaker PH, Cunliffe WJ, Belliveau J et al. Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol 1989; 16 (Suppl 6): 83-97.
2. Hutchins R, Krissat J, Bhattacharya S. (2005) Colorectal Liver Metastases. In: Frontiers in Colorectal Surgery (ed. Phillips RS), pp. 81-88. Frontiers in Colorectal Surgery. TFM Publishing Ltd, Shrewsbury.
3. Elias D, Blot F, El Otmany A et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 2001; 92: 71-76.
4. Sugarbaker PH, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 1999; 6: 727-31.
5. IPG116. Complete cytoreduction and heated intraperitoneal and intraoperative chemotherapy (Sugarbaker technique) for peritoneal carcinomatosis - guidance, 2005: http://www.nice.org.uk/ page.aspx?0=248130 [accessed 1st June 2006].
6. Sugarbaker PH, Jablonski KA. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995; 221: 124-32.
7. Sugarbaker PH (1997) Peritoneal carcinomatosis: Rational therapeutic interventions using intraperitoneal chemotherapy. In: Surgery for Gastrointestinal Cancer (ed. Wannebo HJ), pp. 808-19. Lippincott Raven, New York.
8. Verwaal VJ, van Tintern H, van Ruth S, Zoetmulder FAN. Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy. Br J Surg 2004; 91: 739-46.
9. Glehan O, Cotte E, Schreiber V, Sayag-Beaujard AC, Vignal J, Gilly FN. Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with carcinomatosis of colorectal origin. Br J Surg 2004; 91: 747-54.
10. Loggie BW, Fleming RA, McQuellan RP, Russell GB, Geisenger KR. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin. Am Surg 2000; 66: 561-8.
11. Chu DZ, Lang NP, Thompson C, Osteen PK, Westbrook KC. Peritoneal carcinomatosis in nongynecological malignancy. A prospective study of progmostic factors. Cancer 1989; 63: 364-7.
12. Carraro PG, Segala M, Cesana BM, Tiberio G. Obstructing colonic cancer: failure and survival patterns over a ten-year follow-up after one-stage curative surgery. Dis Colon Rectum 2001; 44: 243-50.
13. Jayne DG, Fook S, Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg 2002; 89: 1545-50.
14. Russell AH, Pelton J, Reheis CE, Wisbeck WM, Tomg DY, Dawson LE. Adenocarcinoma of the colon: An autopsy study with implications for new therapeutic strategies. Cancer 1985; 56: 1446-51.
15. Sadeghi B, Arvieux C, Glehen O et al. Peritoneal carcinomatosis from non-gynecological malignancies: Results of the EVOCAPE 1 multicentric prospective study. Cancer 2000; 88: 358-63.
16. Sugarbaker PH. Patient selection and treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer. World J Surg 1995; 19: 235-40.
17. Pestieau R, Sugarbaker PH. Treatment of Primary Colon Cancer with peritoneal carcinimatosis: Comparison of Concomitant versus Delayed Management. Dis Colon Rectum 2000; 43: 1341-8.
18. Sugarbaker PH, Ronnett BM, Archer A et al. Management of pseudomyxoma peritonei of appendiceal origin. Adv Surg 1997; 30: 233-80.
19. Sugarbaker PH. Cytoreductive surgery and perioperative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Eur J Surg Oncol 2001; 27: 239-43.
20. Hinson FL, Ambrose NS. Pseudomyxoma peritonei. Br J Surg 1998; 85: 1332-9.
21. Moran BJ, Cecil TD. The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg Oncol Clin N Am 2003; 12: 585-603.
22. Murphy E, Payne R, Farquharson SM, Meade B, Sexton R, Cecil TD, Moran BJ. Operative findings, pathological features and early outcomes in 123 perforated appendiceal tumours presenting as pseudomyxoma peritonei. Colorectal Dis 2005; Suppl 1: 76.
23. Shen P, Levine EA, Hall J et al. Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis. Arch Surg 2003; 138: 26-33.
24. Miner TM, Shia J, Jaques DP, Klimstra DS, Brennan MF, Coit DG. Long-term survival following treatment of pseudomyxoma peritonei: An analysis of surgical therapy. Ann Surg 2005; 241: 300-8.
25. Beaujard AC, Glehan O, Caillot JL et al. Intraperitoneal chemothermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer 2000; 88: 2512-9.
26. Cavaliere F, Perri P, Di Filippo F et al. Treatment of peritoneal carcinomatosis with intent to cure. J Surg Oncol 2000; 74: 41-44.
27. Fujimura T, Yonemura Y, Fujita H et al. Chemohyperthermic peritoneal perfusion for peritoneal dissemination in various intra-abdominal malignancies. Int Surg 1999; 84: 60-66.
28. Piso P, Bektas H, Werner U et al. Improved prognosis following peritonectomy procedures and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from appendiceal carcinoma. Eur J Surg Oncol 2001; 27: 286-90.
29. Rey Y, Porcheron J, Talabard JN, Szafnicki K, Balique JG. Carcinoses peritoneales traitees par chiurgie de reduction tumorale et chimiohyperthermie intraperitoneale. Ann Chir 2000; 125: 631-42.
30. Witcamp AJ, De Bree E, Kaag MM et al. Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin C in patients with peritoneal carcinomatosis of colorectal origin. Eur J Cancer 2001; 37: 979-84.
31. Verwaal VJ, van Ruth S, De Bree E et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003; 21: 3737-43.
32. Moran BJ, Kukerjee A, Sexton R. Operability and early outcome in 100 consecutive laparotomies for peritoneal malignancy. Br J Surg 2006; 93: 100-104.
33. Jacquet P, Stephens AD, Averbach AM, Chang D, Ettinghausen SE, Dalton RR, Steves MA, Sugarbaker PH. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intra-peritoneal chemotherapy. Cancer 1996; 77: 2662-9.
34. Stephens AD, Alderman R, Chang D, Edwards GD, Esquivel J, Sebbag G, Steves MA, Sugarbaker PH. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intra-operative intra-peritoneal chemotherapy using the coliseum technique. Ann Surg Oncol 1999; 6: 790-6.
35. Elias D, Pocard M, Sideris L et al. Preliminary results of intraperitoneal chemohyperthermia with oxaliplatin in peritoneal carcinomatosis of colorectal origin. Br J Surg 2004; 91: 455-6.